Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: First Quarter 2025 (ended March 31, 2025)
Filing Date: May 28, 2025
This filing serves as a conduit for the Company's press release titled "IceCure Medical Reports First Quarter 2025 Financial Results," which is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for Form 6-K and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, no specific financial metrics can be extracted from this document.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Such information is contained within the referenced press release.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These disclosures are expected to be found in the full text of the press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for specific Q1 2025 revenue and net loss figures.
- Verify cash position and burn rate details in the attached financial results.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm if the press release includes updated full-year 2025 guidance.